Quick answers
- What is Hextend?
- Hextend is a brand name of Hetastarch, a prescription medicine. The FDA NDC Directory lists 1 Hextend product in 1 strength and form.
- Who makes Hextend?
- Hospira, Inc. lists 1 of the 1 Hextend products in the FDA NDC Directory.
- Is there a generic or store brand of Hextend?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Hextend product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Hextend been recalled?
- FDA enforcement reports list 1 recall of Hextend products; the newest started October 22, 2012. A recall usually concerns specific lots, not every product.
What Hextend is
Each Hextend product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Hetastarch · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| hetastarch 6% injection, solution (intravenous) | Hextend | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Hetastarch →
FDA approval
No Drugs@FDA application is linked to these products.
Companies that list Hextend
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Hextend products.
- Hospira, Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
October 22, 2012 · Class II · Terminated · D-184-2013
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54 — Hospira Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.